Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Perrey

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Psychopharmacology|July 2, 2017
Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signalingK A Levy, Z D Brodnik, J K Shaw, et al.
Journal of Medicinal Chemistry|August 15, 2013
Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptorDavid A Perrey, Nadezhda A German, Brian P Gilmour, et al.
British Journal of Anaesthesia|August 22, 2020
Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primatesHuiping Ding, Norikazu Kiguchi, David A Perrey, et al.
Journal of Medicinal Chemistry|June 8, 2021
Discovery of Arylsulfonamides as Dual Orexin Receptor AgonistsDehui Zhang, David A Perrey, Ann M Decker, et al.
Bioorganic & Medicinal Chemistry|July 29, 2015
The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptorDavid A Perrey, Ann M Decker, Jun-Xu Li, et al.
Journal of Medicinal Chemistry|February 7, 2023
Improvement of the Metabolic Stability of GPR88 Agonist RTI-13951-33: Design, Synthesis, and Biological EvaluationMd Toufiqur Rahman, Ann M Decker, Sami Ben Hamida, et al.
ACS Chemical Neuroscience|February 3, 2015
Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptorDavid A Perrey, Nadezhda A German, Ann M Decker, et al.
Diagnostic and Interventional Imaging|March 20, 2019
Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRIN Lassau, T Estienne, P de Vomecourt, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Psychopharmacology|July 2, 2017
Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signalingK A Levy, Z D Brodnik, J K Shaw, et al.
Journal of Medicinal Chemistry|August 15, 2013
Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptorDavid A Perrey, Nadezhda A German, Brian P Gilmour, et al.
British Journal of Anaesthesia|August 22, 2020
Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primatesHuiping Ding, Norikazu Kiguchi, David A Perrey, et al.
Journal of Medicinal Chemistry|June 8, 2021
Discovery of Arylsulfonamides as Dual Orexin Receptor AgonistsDehui Zhang, David A Perrey, Ann M Decker, et al.
Bioorganic & Medicinal Chemistry|July 29, 2015
The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptorDavid A Perrey, Ann M Decker, Jun-Xu Li, et al.
Journal of Medicinal Chemistry|February 7, 2023
Improvement of the Metabolic Stability of GPR88 Agonist RTI-13951-33: Design, Synthesis, and Biological EvaluationMd Toufiqur Rahman, Ann M Decker, Sami Ben Hamida, et al.
ACS Chemical Neuroscience|February 3, 2015
Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptorDavid A Perrey, Nadezhda A German, Ann M Decker, et al.
Diagnostic and Interventional Imaging|March 20, 2019
Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRIN Lassau, T Estienne, P de Vomecourt, et al.
Pageof 2